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Biotechnology plays a critical role in treating war injuries, preventing and diagnosing 
disease, and protecting the force against exposure to harmful agents. While effective in 
its ability to provide medical intervention, biotechnology’s non-medical side reveals 
opportunity to create a “super human” soldier who is more effective in combat and 
equipped to survive the rigors of war. Scientists in the field have proposed ideas on how 
to neurologically and physically enhance soldiers at the genetic level. These 
developments may help build soldier resistance to battle fatigue, increase endurance, and 
enhance intelligence making soldiers more decisive on the battlefield. Creating soldier 
that are stronger, faster and able to counter unpredictable enemy tactics will increase the 
military’s ability to adapt to changing battlefield conditions and conduct major operations 
using a smaller force. This thesis examines performance and cognitive enhancement of 
the soldier via genetic engineering and its potential ability to arm the military with the 
capabilities to maintain rapid deployment cycles despite the reduction in force and fight 
wars using sophisticated techniques in order to reduce casualty rates. Understanding the 
ends and means of soldier enhancement and the novel ethical issues associated with 
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A. MAJOR RESEARCH QUESTION 
When deploying into combat, the primary mission of the United States military is 
to achieve battlefield superiority and a decisive defeat of its enemy. In compliance with 
the Clauzewitzian principle of “compelling our opponent to fulfill our will,” the U.S. 
does not engage in conflict it cannot win and relies heavily upon its technical and 
industrial capabilities to design weapons systems that outmatch the capabilities of its 
potential adversaries.1 While evolutionary technologies continue to change the conduct of 
war, the human factor remains constant. By means of its military tactics, the human 
soldier has always been the most essential and decisive weapon on the battlefield, but 
unlike M1A2 tank and the MQ-9 Reaper, the natural limitations of the human genome 
confines a soldier’s war fighting capabilities. This factor makes the soldier highly 
susceptible to the hardships of warfare. Biotechnological enhancement of the soldier, 
however, could increase physical and cognitive abilities and increase their overall 
survivability of soldiers.  
The inevitable controversies that encompass America’s involvement in conflict 
abroad is not enough to gain public acceptance of, or ease societal concerns about 
modifying the human genome for military effectiveness. The idea of genetically altering 
a human being poses difficult questions for normative beliefs on the conduct of life and 
the natural evolution of man. These concerns held by both the public and policy makers, 
have a direct impact on the development and application of future technology. The 
scientific concepts and ethical issues surrounding the use of biotechnology for human 
enhancement are numerous and this thesis does not aim to address or provide sound 
solutions for all of them. Instead, the goal is to enhance awareness, guide future thinking 
in applying enhancement technology to the solider, and assess the feasibility of  
 
                                                 
1 Carl Von Clausewitz, On War, eds. and trans. Michael Howard and Peter Paret (Princeton, NJ: 
Princeton University Press, 1976), 75.  
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performance enhancement via genetic modification of the soldier. Is there a legitimate 
need for this method of performance enhancement? Additionally, does the ethical debate 
amongst biopolitical parties consider the operational needs of the military?  
B. IMPORTANCE  
One of the long-term goals of biotechnology is the ability to manipulate the 
human genome. This science promises unlimited capabilities that extend beyond the 
realm of medicine. Whether aimed to protect an individual from exposure to infectious 
disease or enhance the soldier by increasing mental acuity and physical abilities, human 
enhancements will increase the capabilities of the American soldier. While these 
modifications will potentially benefit the armed forces, the institution will face moral, 
legal, and political implications associated with research that intends to modify human 
beings. Human enhancement is a contentious subject. Within it lies an assortment of 
opinions on the capabilities it can provide and positions for or against its continued 
research. Irrespective of the ongoing debate, the Defense Advanced Research Projects 
Agency (DARPA) and other research organizations grow closer to ground breaking 
innovations that could have a major impact on the institutional practices of the DoD. 
Therefore, novel concerns in ethics and policy require considerable attention to fill the 
gap between the development of appropriate regulation and ongoing scientific 
advancement. Furthermore, military mission and requirements must bear weight in the 
discussion of ethics and policy. This will both prevent the development of restrictions 
that may stifle the procurement of valuable enhancement capabilities and ensure that 
military applications are subjected to rigorous oversight. 
Biological sciences are unveiling a multitude of human enhancement 
opportunities that may affect the future conduct of war.2 Improved knowledge of the 
factors that control the generation and operation of organisms has enabled innovation 
within the biosciences, unlocking pathways to more advanced research that aims to alter 
                                                 
2 William D. Casabeer, “Ethics and the Biologized Battlefield: Moral Issues in the 21st-Century 
Conflict,” Bio-Inspired Innovation and National Security (Washington DC: National Defense University 
Press, 2010), 294. 
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and control organisms at the genetic level. Biotechnology is an open market industry, 
available to those who wish to control and make use of all it has to offer, hence, it is 
spreading throughout the global community at an unprecedented pace. In addition to our 
allies, adversarial states such as Iran, China, Russia, and North Korea have commercial 
biotechnology facilities and possess the capabilities to conduct advanced research. 
Therefore, with U.S national security as the top priority, it is of the utmost importance to 
equip our institutions with the necessary tools to protect the homeland from emerging 
threats. Biotechnology plays a critical role in treating war injuries, preventing and 
diagnosing disease, and protecting the force against exposure to harmful agents, but it 
also reveals opportunities to create a “super” soldier. Scientists have proposed ideas for 
neurological and physical enhancements of soldiers at the genetic level to help build 
resistance to battle fatigue, enhance sensing and monitoring of the battlefield, aid faster 
recovery, and endure extreme conditions and extended operations.3 Ideally, these 
enhancements would increase force ability to adapt and adjust to changing battlefield 
conditions and conduct major operations using a smaller force by creating a soldier who 
is stronger, faster, has more endurance, and is better protected against unpredictable 
enemy tactics.4  
The most important aspect of this discussion is the livelihood of the soldier. While 
a last resort option, the military often becomes the default response to adversarial 
pressures, placing soldiers in harm’s way to defend America’s freedom and interests.5 
For the military, budget cuts will lead to a reduction of personnel but will not reduce the 
operational requirements to sustain enduring overseas missions. The need to reduce 
casualties has also become a limiting factor on military operations, because leaders are 
                                                 
3 Guo Ji-wei and Xue-sen Yang, “Ultramicro, Nonlethal, and Reversible: Looking Ahead to Military 
Biotechnology,” Military Review, accessed June 4, 2013, 
http://www.army.mil/professionalWriting/volumes/volume3/october_2005/10_05_4_pf.html, 75.  
4 National Research Council, Opportunities in Biotechnology for Future Army Applications 
(Washington DC: National Academy Press, 2001), accessed June 4, 2013, 
http://www.nap.edu/catalog/10142.html, 1–4, 6. 
5 D. Robert Worley, Orchestrating the Instruments of Power: A Critical Examination of the U.S. 
National Security System (Raleigh: Lulu Press, 2012), accessed June 4, 2013, 
www.drworley.org/Pubs/Orchestrating/, 2.  
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increasingly risk averse due to public response to soldier deaths. Additionally, the 
humane treatment of the enemy has captured public attention reinforcing international 
prohibitions against the use of weapons of mass destruction that would cause mass 
casualties. This increases the need for small unit tactics vs. large weapons attacks to 
defeat an enemy. Some strategists believe a more humane war would reduce American 
post-reconstruction efforts and reduce long-term political ramifications.6 Yet, as seen in 
the conflicts in Iraq and Afghanistan, reconstruction and humanitarian missions, though 
nonlethal, are not necessarily peaceful and can last for many years. Therefore, 
enhancement of the Soldier via biotechnological methods may arm the military with the 
capabilities to maintain rapid deployment cycles despite the reduction in force, fight wars 
using sophisticated techniques in order to reduce casualty rates, and may potentially 
increase humanness in the conduct of war by potentially delivering more targeted and 
reversible damage to the enemy.  
Unlike the soldiers in WWII, today’s soldier faces an enemy that employs 
asymmetric tactics to weaken its opponent. When a traditional fight against two armies 
becomes a fight between an army and sect of unlawful combatants, the law of armed 
conflict is greatly altered. Evidence presented from the conflicts in Iraq and Afghanistan 
show that overwhelming military superiority alone is not effective in countering 
asymmetric threat. Lessons learned in both theaters show that the tactics of the individual 
soldier and small units is the most important weapon when fighting against a complex 
enemy. Unlike our most lethal weapons systems, soldiers have limits and are vulnerable 
to the rigors of war. Protracted wars take a toll on the human domain (i.e., battle fatigue, 
combat stress, increased vulnerability to surprise attacks, and prolonged exposure to 
foreign climates, and terrain). Therefore, there is an increasing need to enhance the 
physiological and mental capabilities of the warfighter. Equipping a soldier with 
enhanced cognitive functioning and superior physical abilities will allow them to survive 
the rigors of war and allows the U.S. to maintain a superior military advantage. While 
these modifications may potentially benefit the armed forces, there are several moral, 
                                                 
6Ji-wei and Yang, “Ultramicro, Nonlethal, and Reversible,” 75. 
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legal, and political implications associated with its research and application to humans. 
Some potential questions include: How does genetic enhancement effect the organization 
structure of military units, are the enhancements reversible to prevent spillover into 
society when soldiers are discharged from the army, and most importantly once 
achievable how will the military employ these soldiers in combat. For the sake of space, 
this thesis will not address these aforementioned questions but they all require further 
research before the technologies reach fruition and soldiers undergo enhancement.  
Biotechnology not only promises to enhance the soldier, it also proposes more 
aggressive capabilities to control and incapacitate enemy force by creating weapons 
designed to manipulate the genes of the enemy. These weapons would deliver a stronger 
and more civilized blow to the enemy versus the catastrophic results produced by 
conventional weapons systems. In adherence to treaties against the use of biological 
weapons, biotechnological weapons would replace traditional biological agents via lab 
manipulation and genetic engineering creating a more controllable and reversible 
weapons system. Creating more controllable weapons may increase public and 
international support of its use in future conflicts.7 Though compelling this thesis will not 
discuss this in further detail but the implications demand further analysis. 
This thesis examines the promised performance enhancement capabilities that 
biotechnology has to offer and their benefits to the individual soldier and DoD war 
fighting capabilities. Whether restructured to fight states or prolonged insurgencies, 
biotechnology may increase soldier capabilities in individual command and control, 
mobility, lethality, sustainability and survivability, while decreasing their vulnerability on 
the battlefield. This would allow the U.S. to maintain military superiority and therefore 
facilitate Washington’s national security objectives.  
C. PROBLEMS AND HYPOTHESIS 
Performance enhancement via biotechnological means will open the door to a 
multitude of military capabilities by improving the overall war fighting abilities of the 
                                                 
7 Ibid., 78. 
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U.S. soldier, however, ethical barriers will limit its application and potential use in 
combat. Genetic modification is a potentially game changing concept, but existing 
information mostly focuses on futuristic and unproven ideas. The uncertainty surrounding 
the science and the ends and means by which biotechnology could enhance humans 
sparks a great deal of public concern. To draw an appropriate hypothesis on the potential 
benefits of genetic modification and the implications of applying these scientific 
enhancements to the force several questions need clarification. This thesis will assess the 
following questions: 
• What does it mean to “enhance” a human? 
• What is the feasibility of creating and controlling the means to genetically 
alter a soldier? 
• How much of the ethical debate is based on actual science vs. drawn 
hypothetical conclusions based on the philosophical roots of each 
biopolitical party? 
First, biotechnology promises an outcome for scientific intervention, 
“enhancement.” Current discussions center on the term without a clear working definition 
that generates a line of distinction between ethical and immoral uses of biotechnology. 
Enhancement in of itself is a simple term that means “to exceed the current state of 
being.” Human enhancement denotes changes made to the mind and body to increase 
capacities, abilities, and characteristics beyond its natural limits. In the later use of the 
term, it becomes more complex and raises novel ethical questions about the effects on 
human dignity, and society. It forces question of how radical changes will affect the 
present-day meaning of life. The greatest ethical concerns stem from the uncertainty of 
the science and an unclear understanding of the ends, means, and motivation for its use. 
Because of the link between biotechnology and medical innovation, the word 
“enhancement” in this thesis implies using biotechnology to increase natural human 
abilities beyond the limits of “normal” health.   
Second, significant data suggests the improved capabilities that biotechnology 
promises, but little empirical data exists on whether these capabilities are truly 
achievable. While enthralling, the concepts of biotechnology appear futuristic and lack 
real and definite planning for future testing and implementation. This realm of science 
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promises to enhance future combat capabilities but the basis of its research is an 
unproven science. Genetic research is associated with several complexities and 
uncertainty that make it difficult to achieve targeted goals. Research starts with an 
assumption based on historical data but is ultimately subject to evolutionary changes 
associated with living organisms. For example, research in human performance 
modification (HPM) has uncovered computational issues in cognitive modification and 
biological issues in tissue engineering. In order to enhance cognitive function, researchers 
apply computers to the human body that interconnect with their natural neurological 
process. This computer to neuron interface intended to advance sensory, communication, 
and overall cognition. However, current computational devices are incompatible with the 
complex cognitive processes of the human brain.8 Like cognitive modification, tissue 
engineering intends to improve human performance by increasing recovery and 
improving the quality of regenerated tissues. While this field of study has successfully 
accomplished these tasks, tissue engineering methods remain unable to enhance the 
normal cellular performance of healthy tissue. Because this study requires direct contact 
with human subjects, scientists remain unable to overcome challenges in obtaining an 
adequate number of sustainable cells to conduct advanced research.9 Scientists can 
expect to face unknowns that are hard to predict in the preliminary stages of research. 
Current information regarding biotechnology suggest that research is not too far off from 
uncovering the keys that will make these concepts reality but none are clear on just how 
close. This thesis will attempt to determine the feasibility of the proposed studies in 
genetic modification of human physiology and cognition and it potential use to advance 
the force.10 
Lastly, ethical dilemmas present the most profound barriers within the field of 
human enhancement research. There is no way to predict what the enemy or conflict will 
look like in the next 30 years but the assumption is the soldier will remain the center of 
                                                 
8 National Research Council, Human Performance Modification: Review of Worldwide Research with 
a View to the Future (Washington, DC: National Academies Press 2012), 2. 
9 Ibid., 4. 
10 Ji-wei and Yang, “Ultramicro, Nonlethal, and Reversible,” 78. 
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gravity for future combat operations. Information alludes to an ever-present social 
sensitivity to the use of biological agents and the manipulation of human genes. The 
uncertainty and unpredictability associated with biotechnology and the ends and means 
by which is aims to enhance human’s sparked debate among ethicist and political elites. 
Each party struggles to define the proper use and limits of the science to protect or better 
society. The argument focuses on the need for enhancement within the general populace 
of civilians and little emphasis on those that defend the freedom of the nations. Service 
member responsibilities are vastly different and more complex than of the general 
populace. What remains unanswered is whether the ethical debate will lead to the 
development of policy that strikes a balance between the needs of society and the 
military. This thesis will address these issues as they pertain to the study of human 
enhancement via genetic engineering, and its future military application.  
D. METHODS AND SOURCES 
This thesis will use existing research and data on genetic engineering to provide 
an explanation of present biotechnology and the human enhancement capabilities it could 
potentially provide to the military. Due to the lack of empirical data on how human 
enhancements will affect DoD policy, this project will use historical data on the effects of 
the use of force enhancement methods on military operations and policy to draw a 
hypothesis. An essential aspect of this study is an analysis of the ethics that govern 
scientific research and the biopolitical debate that affect research involving human 
subjects. Therefore, this thesis will examine and compare the schools of ethics, their 
philosophical basis that drives their understanding of human enhancement, and the push 
for legislative control over the life sciences that will potentially stifle human 
enhancement research and application methods. This analysis will potentially lead to a 
proposed policy recommendations that enable flexible research and effectively govern the 
practice of performance enhancement via biotechnology. The next chapter is a review of 
the literature that addresses human enhancement and public concerns of genetic 
modification.   
 9 
The next chapter will identify and compare the biopolitical parties to include 
differences and similarities in their philosophical roots. This analysis will help with 
understanding the concerns addressed within the debate, assess how hypothetical 
assessments are based on scientific fact, and whether ethical exceptions are possible 













THIS PAGE INTENTIONALLY LEFT BLANK 
 11 
II. LITERATURE REVIEW 
This section will provide an overview of the existing schools of thought on the 
potential capabilities of human enhancement, discuss bioethical theory and institutional 
issues that effects human enhancement research. The study of human enhancement is 
uncharted territory with limited data addressing actual case studies of successful 
application. Most of the works are speculative in nature, hypothesizing future capabilities 
by using data from existing deoxyribonucleic acid (DNA) studies and micro-level 
research. While there is an array of literature that provides a general overview on ethics, 
few discuss bioethical implications associated with military use. A few articles provide a 
brief overview of the laws that prohibit misuse of biotechnological material and the 
institutional issues that affect continued research within the field of study. The scope of 
this literature review is limited to the concepts and findings presented in journal articles, 
scholarly works, academic reports, and open source data from government and other 
informational websites that discuss genetic engineering to enhance human performance.  
A. BIOTECHNOLOGY: HOW IT PROMISES TO ENHANCE NATURAL 
HUMAN ABILITIES 
Throughout history, humans have tried to find new ways to advance the species 
beyond its natural biological abilities. Some examples are the creation of contraceptives 
to control the reproductive cycle, the invention of plastic surgery to enhance physical 
appearance, and the production of prosthetics designed to replace lost sensory and 
improve the natural abilities of a missing limb. A London exhibit called “Super Human” 
that opened in July of 2012 highlighted historical examples of various cultural attempts to 
modify the human body. The exhibit displayed a range of artifacts from ancient Egyptian 
prosthetics to modern day science fiction images that depict the futurist ideas of the 
physical enhancements that nano- and biotechnology promise. Emily Sargent, Curator of 
the “Superhuman” exhibit, describes human enhancement as “one of the most exciting 
and feared areas of modern science” and the artifacts prove that the ideas are “not an 
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exclusive preserve of the contemporary technologist, as our desire to enhance ourselves 
and our ingenuity to do so is in evidence throughout our history [emphasis added].”11 
Therefore, it is not surprising that modern day scientists would leverage the 
advancements in biotechnology while studying new and innovative methods to enhance 
the human species. 
Before discussing capabilities, there must be a clear understanding of what the 
term “human enhancement” means. Definitions expressed throughout the literature 
commonly describe human enhancement as actions designed to restore or improve human 
performance, hence enabling a person to overcome imposed or natural limitations.12 
Memory, hearing, sight, strength, and mobility are examples of the human functions this 
research intends to improve. Due to the complex nature of the human genome, the 
collaboration of various disciplines including biotechnology, engineering, neuroscience, 
and computing is necessary to conduct research and create functional systems.13 A joint 
board study lead by the National Academy of Science (NAS) took their research a step 
further by assessing the effects of human enhancement in the workplace. Their 
hypothesis is that the use of enhancements may influence a person’s ability to learn and 
conceptualize key tasks within a profession, motivate the pursuit of a profession, enable 
an individual to work in more extreme conditions for longer periods, reduce work related 
illness, and facilitate faster recovery times to reduce time away from work.  
Although these capabilities are compelling, preexisting social and ethical beliefs 
make the marketing of these ideas difficult. Therefore, more education is necessary to 
reduce public fear of biotechnological enhancements. The board agreed that the 
implications of human enhancements on the workplace and the long-term health effects 
                                                 
11 Tim Morley, ed., “Wellcome Collection Press Release,” July 2012, accessed June 11, 2013, 
www.wellcomecollection.org/press/press-releases/superhuman.aspx.  
12 Academy of Medical Sciences, the British Academy, the Royal Academy of Engineering, and the 
Royal Society, “Human Enhancement and the Future of Work,” accessed on June 11, 2013, 
http://royalsociety.org/uploadedFiles/Royal_Society_Content/policy/projects/human-enhancement/2012-
11-06-Human-enhancement.pdf, 7. 
13 Ibid., 9.  
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on the individual are areas of the study that require further examination.14 A 
biotechnology review conducted by the Boards of Army Science and Technology (AST) 
and the Royal Society reveals similar theories. In the military workplace, a soldier is 
required to perform basic human functions while detecting and protecting themselves 
from danger, differentiating friendly from enemy forces, and surviving unforeseen 
changes on the battlefield.15 In the combat zone, genetic enhancements provide increased 
strength, endurance, and marksmanship abilities while reducing battle fatigue, combat 
stress, and increased regenerative abilities to reduce force reduction.16 Researchers 
predict the application of biotechnological enhancements to the individual soldier will 
increase combat capability and effectiveness within the organization. In an institution 
where physical characteristics and performance are the key criteria’s used to subdivide 
and select soldiers for specific duties or units, advanced studies of the human genome 
could allow for better pairing of an individual with their appropriate job. Both research 
boards agree that the ethics of enhancement and guidelines of use must be resolved in 
order to increase public support and continue research to further advancements.17 
Equipping the force for the future combat environment is an ever-present theme that 
appears throughout the literature but what is the future combat environment and what 
does that mean for the military?  
Scientists Guo Ji-wei and Xue-sen Yang describe the future battlefield as one that 
relies heavily on cyber technology, communications, and micro-information to stay 
abreast of enemy activity and sense changes on the battlefield.18 They believe the need 
for information dominance in the modern era drives the study of human genetics and the 
enhancement of soldier capabilities. Aligned with previous assessments, these scientists 
                                                 
14 Ibid., 53.  
15 Rod Flower et al., “Brain Waves Module 3: Neuroscience, Conflict, and Security,” Excellence in 
Science 6, no 11 (2012), accessed July 11, 2013, 
http://royalsociety.org/uploadedFiles/Royal_Society_Content/policy/projects/brain-waves/2012-02-06-
BW3.pdf, 5. 
16 National Research Council, Opportunities in Biotechnology, 63. 
17 Ibid. 
18 Ji-wei and Yang, “Ultramicro, Nonlethal, and Reversible,” 75.  
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believe that the laws, rules, and essential qualities of genetic modification remain unclear. 
Therefore, to reduce the fear and uncertainty associated with this type of research, 
applied enhancements must be ultra-micro, nonlethal, and its effects reversible. Their 
position is if America wants to take and maintain control of the battlefield, it must pursue 
biotechnological enhancement of the force to stay abreast of the evolutionary changes to 
global conflict and secure national and strategic objectives.19  
While genetic modification of the human genome is somewhat hypothetical, the 
research presented within this subsection declares it an important and testable concept. 
Future advancements within this field of study require public support and a clear 
understanding of its potential benefits, and the potential effects on an individual, 
organization, and social institutions.  
B. THE EMERGENCE OF BIOPOLITICS: THE BIOCONSERVATIVES, 
BIOPROGRESSIVES AND TRANSHUMANISTS 
The literature poses significant questions on whether the ideas of human 
enhancement will pass the bioethical test or whether moral and social norms ultimately 
hinder continued research and future application. Research indicates an increasing 
overlap between biology and politics in the ever-present fight between bioethical parties 
over control of the life sciences.20 While the prospect of human enhancement advertises 
great benefits, it sparks great debate between the bioconservatives, bioprogressives and 
the small, but rising group the transhumanists on the question of safety, efficacy, and 
morality of its use. Ethicist Jonathan Moreno states that each of the camps possess 
different understandings of the effects that science has on humanity, with human 
adaptability to moral challenges at the heart of the philosophical debate.21  The 
bioconservatives believe enhancement by either medical or technological methods are 
inhumane. Their goal is to greatly restrict or ban research and future application because 
                                                 
19 Ibid., 77. 
20Jonathan D. Moreno, The Body Politic: The Battle Over Science in America (New York: Bellevue 
Literary Press, 2011), Kindle edition, loc. 209. 
21Ibid., loc. 318–19. 
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it violates social and moral values. The primary fears that drive the bioconservative 
argument is the belief that enhancing humans will degrade or cause more harm to society 
and that “posthumans” may pose a threat to normal citizens.22 Contrarily, the 
bioprogressives are in favor of private enterprise and innovation and promote the use of 
biotechnology to increase the capabilities of mankind. Within this camp is a dividing line 
between right wing activists that believe in liberty and free enterprise as the greatest 
sources of innovation and the left wing activists that believe in regulation of 
biotechnology and equality of use for the greater good of society. Like the bioprogressive 
party, the transhumanists are in favor of using biotechnology to enhance humans but they 
adopt the position that technology will promote the factors of human life that the 
bioconservatives fight to protect (i.e. human dignity and the natural essence of human 
life).23 
The book, Radical Evolution, by Joel Garreau, draws a literary illustration of the 
debate between the ethical camps. Garreau begins by describing human enhancement as a 
melding of genes, robotic information, and nano-technologies to create unrecognizable 
change in society.24 While he holds no distinct position within the debate, Garreau 
creates three scenarios known as the heaven, hell, and prevail scenarios, each of which 
describe the hypothetical future of humanity and the potential effects of accelerating 
evolution by technological means. The Heaven Scenario describes a world of post 
humans within the next 20 years whereas the Hell Scenario describes the end of humanity 
due to rapid and unprecedented technological advancement. Lastly, the Prevail Scenario 
describes humanity coming to grips with evolutionary changes and taking control of their 
destinies. People that embrace the Prevail Scenario will entrust their futures in the laws of 
 
 
                                                 
22 Nick Bostrom, “In Defense of Posthuman Dignity,” Bioethics 19, no. 3 (2005): 204. 
23 Moreno, The Body Politic, loc. 318–19. 
24 Joel Garreau, Radical Evolution: The Promise and Peril of Enhancing Our Minds, Our Bodies, and 
What It Means to Be Human (New York: Doubleday, 2005), accessed on June 12, 2013, 
http://www.garreau.com/main.cfm?action=chapters&id=52.  
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natural evolution and human decision. While Garreau believes, the actual future may be a 
combination of the three scenarios, the fight for theoretical dominance continues between 
the parties that embrace each scenario.25  
In support of the heaven scenario, bioprogressive Nick Bostrom is in favor of 
using technology to advance human abilities, and believes the results are socially 
desirable.26 Like others within his camp, Bostrom is an advocate of embracing the 
advancements of biotechnology while establishing strong policies to defend human rights 
and taking action against concrete threats such as biotechnological use by terrorist 
organizations.27 Bostrom believes the bioconservative view is one based on religion or 
secular grounds and considers them a camp that lacks clearly defined rationale to support 
their arguments. Prominent bioconservative Leon Kass, who holds a vastly different 
opinion, states: 
…the use of biotechnical powers to pursue ‘perfection,’ both of body and 
of mind—is perhaps the most neglected topic in public and professional 
bioethics. Yet it is, I believe, the deepest source of public anxiety about 
biotechnology, represented in the concern about ‘man playing God,’ or 
about the Brave New World, or a ‘posthuman future.’28  
Kass views innovation in biotechnology as a potential risk to the dignity and 
essence of humanity, one that society may not overcome. Bioconservative Francis 
Fukuyama takes the argument a step further deeming transhumanism as “the world’s 
most dangerous idea” and believes society is at risk of abolishing equal rights by 
partaking in biotechnological enhancement.29 He questions whether enhanced humans 
will claim additional rights to set them apart from the ordinary class, which will 
ultimately draw a wedge between groups and lead to a future political fight over human 
                                                 
25 Ibid. 
26 Nick Bostrom, “In Defense of Posthuman Dignity,” 203.  
27 Ibid. 
28 Leon Kass, Beyond Therapy: Biotechnology and the Pursuit of Happiness (Washington, DC: 
President’s Council on Bioethics, 2003), 7. 
29 Francis Fukuyama, “Transhumanism,” Foreign Policy, September 1, 2004, 
http://foreignpolicy.com/articles/2004/09/01/transhumanism.  
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rights.30 Transhumanist Ray Kurzweil strongly opposes the bioconservative view and 
embraces the idea of technology progressing humans beyond their normal capabilities. 
Kurzweil defines this concept as “singularity” an era that will alter the concept of man 
and give new meaning to the conduct of human life and the natural life cycle of man.31 
Ideally, singularity is the result of the merger between biology and technology that allows 
humans to surpass their biological roots. According to Kurzweil, the final epoch of 
human evolution is an era where human form is no longer strictly biological. 
Technological advancements in modern science will allow humans the ability to 
overcome physical and mental limitations, enable the control of one’s fate and mortality 
by ridding disease and other ailments, and allow the power of the mind to exceed 
unassisted human intelligence.32 This marks the beginning of the merger of man and 
machine where machine ultimately dominates. Kurzweil considers this an inevitable 
implication of the “law of accelerating returns”- exponential growth in technology will 
surpass the natural evolutionary process.33 As a futurist, he believes that 2045 marks the 
beginning of human immortality, and radical life expansion. He shuns the idea that two-
dimensional views of the genome limits scientific research and believes, in a matter of 
time, that computational advancements will allow scientists to visualize and model 
structures that are more complex.34  
Another issue highlighted in the literature is that the debate amongst ethical 
groups has reached a stalemate without achieving a clear consensus on the future of 
human enhancement and its possible application to society.35 While the groups believe 
that individual choice is the key component to human dignity, each group accuses the 
other of using coercive measures to influence the creation of policy that may violate an 
                                                 
30 Ibid. 
31 Ray Kurzweil, The Singularity is Near: When Humans Transcend Biology (New York: Penguin 
Group, 2005), 7. 
32 Ibid., 9. 
33 Ibid., 35. 
34 Ibid., 482. 
35 Rebecca Roache and Steve Clarke, “Bioconservatism, Bioliberalism, and the Wisdom of Reflecting 
on Repugnance,” Monash Bioethics Review 28, no. 1, Art. 4(2009): 2.  
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individual’s freedom of choice.36 Professors of Philosophy Steve Clarke and Rebecca 
Roache state, “whilst moral intuitions can be useful tools in moral deliberation, intuitions 
alone are an unreliable final arbiter of what is right and wrong, and they are highly likely 
to be influenced by social factors…[and]…also susceptible to external manipulation.”37 
With neither group willing to concede to the will of the other, the debate continues. 
Philosophers Patrick Lin and Fritz Allhoff believe the debate is far from resolution and 
that proposed laws on restriction would likely be imperfect or ineffectual where no law at 
all would allow uninhibited enhancements.38 Currently there are no regulations or laws 
that restrict or ban human enhancement research. Instead, existing law intends to restrict 
the creation of novel and increasingly lethal biological or biotechnological agents for 
weapons. Because the “post human” concepts are so futuristic and risk remains 
hypothetical, Roach and Clark believe that without clearly defined risks or posed health 
concerns, the government is less likely to implement legislative restrictions or bans. 
Therefore, in a Western liberal society where no clear policy exists, the liberal view will 
overcome the view of the conservative party.39 
C. THE MILITARY PERSPECTIVE 
Research on the ethical, legal or policy implication within the DoD with reference 
to the use of biotechnology is limited. Yet a few sources address the need for soldier 
enhancement capabilities and the need for policy consideration. For greater perspective, 
discussion begins with an article entitled “The Human Dimension in the Close Fight,” by 
Retired U.S. Army Major General Robert H. Scales. In his article, Scales draws his 
reader’s imagination into combat as member of a tactical squad. As a soldier within this 
team, you are highly competent and equipped with the ability to think linearly and 
                                                 
36 Jess Hasken, “Coercion in Bioethics,” Macalester Journal of Philosophy 16, no. 1, Art. 3 (2007): 
15–16. 
37 Rebecca Roache and Steve Clarke, “Introducing Transformative Technologies into Democratic 
Societies,” Philosophy & Technology 25, no. 1 (2012): 43. 
38 Patrick Lin and Fritz Allhoff, “Untangling the Debate: The Ethics of Human Enhancement.” 
NanoEthics 2, no. 3 (2008): 262. 
39 Roache and Clarke, “Bioconservatism, Bioliberalism, and the Wisdom of Reflecting on 
Repugnance,” 16. 
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because of your heightened senses, you are extremely aware of enemy movement and 
tactics. All members of your team are resilient, low stress, have minimal fear of death or 
of killing the enemy. Most importantly, your team has complete confidence in your 
leaders and supporting units to make superior decisions for the sake of the mission and 
survival of your team. His perspective provides a better understanding of the necessary 
components that drive the success and effectiveness of military missions at the small unit 
level. Training can only go so far to prepare a solider for combat. As a proponent of 
enhancement technologies, MG Scales concludes his article by stating “the best 
investment [is to] use the human sciences to improve the fighting power of close-combat, 
to focus as much on what goes in the soldier and what goes on the soldier.”40 Scales’ 
request is not farfetched because seeking improvement to overcome innate human 
limitations is natural part of the human psyche.  
A recent article written by Dr. Edmund G. Howe addresses the effects of human 
enhancement on military medical ethics. He believes the military mission dictates how 
and whether biological advancements are legitimate for military application and 
employment in combat.41 Gathered from Howe’s comment is the requirement for the 
DOD to reevaluate its traditional institutional practices in order to strike a balance 
between ethics and national security. Human enhancement will not only change the face 
of military medicine, it will also change military operations and soldier conduct in war. 
Therefore, further examination of these practices is necessary to create new policy that 
will regulate the application and use of human enhancement technologies within the 
military. A report conducted by Mehlman et al., states that there is a significant lag time 
between the development of enhancement technologies and the necessary discussion to 
guide its appropriate use.  The group holds a firm opinion that before soldiers undergo 
any form of technological enhancement the government must adequately consider the 
implications of enhancement technologies to include the risks on the soldier, the impact 
                                                 
40Robert H. Scales, “The Human Dimension in the Close Fight,” Army Magazine, May 2012, accessed 
October 24, 2013, 
www.ausa.org/publications/armymagazine/archive/2012/05/Documents/Scales_0512.pdf.  
41Edmund G. Howe, “New Biological Advances and Military Medical Ethics,” Bio-Inspired 
Innovation and National Security (Washington DC: National Defense University Press, 2010), 9. 
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on society when enhanced soldiers return to civilian life, and the possible mishandling of 
biotechnology for malicious use.42 As DARPAs and other institutions research gains 
significant momentum towards breakthroughs in biotechnology, it is of increasing 
importance that DoD leadership examines the moral considerations of military 
enhancement.   
D. CONCLUSION  
Research shows that biotechnology promises new methods to enhance the human 
species beyond its natural limits. Whether biotechnology is used to increase speed, 
sensory, or rapid recovery, it could provide the military with potential capabilities to fill 
operational gaps when conducting future operations. Such capabilities are associated with 
large costs that may affect how the military will act to achieve victory. Overcoming 
ethical hurdles are one of the largest costs that the military must bear to obtain enhanced 
performance of its soldiers. The uncertainty of biotechnological enhancement sparks 
great debate between bioconservatives, who take a religious perspective aimed at 
protecting human dignity and the laws of evolution, and bioprogressives and 
transhumanists, who see this advancement as a natural part of human evolution and its 
proposed benefits as highly desirable. The debate has not reached a consensus on whether 
to ban, restrict, or embrace human enhancement. There is minimal research that applies 
these concepts to the military. Further research is necessary to understand the potential 
effects that enhancement capabilities may have on the individual soldier and on the 
military as an institution. This thesis will analyze the available information on human 
enhancement to provide a basic picture of its potential benefits to the military. The 
literature on the bioethical debate will allow for an adequate comparison of ethical 
camps, and an assessment of how their arguments align with the operational requirement 
of the military.  
                                                 
42 Patrick Lin, Maxwell J. Mehlman, and Keith Abney, “Enhanced Warfights: Risks, Ethics, and 
Policy,” Case Research Paper Series in Legal Studies, January 2013, last modified on September 15, 2013, 
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The next chapter is on force enhancement, what it means, and its importance. The 
discussion will examine military need, historical and current methods to enhance soldiers, 
and the biotechnological breakthroughs in genetic engineering that may provide a 
permanent fix to natural limitations. The next chapter will provide an overview of 
concept of soldier performance enhancement. It will help to understand what 
enhancement means, how the military has used science to sustain and increase 
performance, and the potential force enhancement capabilities that genetic engineering 
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III. ENHANCING THE FORCE: WHAT DOES IT MEAN AND 
WHY IS IT IMPORTANT 
A. INTRODUCTION 
In 1940, Steven Rogers, a tall gaunt man from New York City attempts to enlist 
into the United States Army only to be rejected due to his physical limitations. His 
perseverance to join the fight against the rising power of Nazi Germany captures the 
attention of scientists Abraham Erskine, the lead scientist for “Project Rebirth.” Project 
Rebirth was a secret military project that sought to create the perfect soldier by enhancing 
humans to optimal levels of physical perfection. Injected with a special serum and 
exposed to high levels of atomic energies to activate and stabilize the exogenous 
chemicals, Rogers is reborn from an inherently frail state to one of total human 
perfection. The serum not only enhanced his musculature and brain activity, it also 
increased cellular regeneration ultimately slowing degeneration. Scientific research of 
this caliber did not end with Steven Rogers. It improved with the introduction of novel 
technologies and the release of investigative findings. In the early twenty-first century, 
Private First Class Kenneth J. Kitsom, a solider recruited into the Army despite of his 
sub-average IQ and cognitive disability. Soon after his training, he was spuriously 
declared dead as a result of a roadside bomb during the Iraq War. Kitsom’s contrived 
death masked his recruitment into “Operation Outcome,” a clandestine special operations 
program designed to create the ideal field operative by altering the chromosomes that 
controlled physical and mental abilities. Scientists used manufactured viruses to achieve 
their proposed effects and a series of medications called “chems” to control and maintain 
the genomic changes. Like Rogers, Kitsom also experienced increased muscle efficiency, 
strength, and intelligence, but new genetic advancements allowed Kitsom to suppress 
extreme pain and execute a level of mental improvisation and linear problem solving 
unrealized by the typical special operator. 
These two fictional depictions may sound familiar. That is because they are 
describing the popular comic book character Captain America, and Bourne Legacy film 
character Aaron Cross. Advancements in biotechnology allowed scientists to genetically 
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modify these soldiers and create specially designed biopharmaceuticals to stabilize and 
solidify the changes made to their genomes. Project Rebirth and Operation Outcome are 
fictional scientific programs, but the idea of using biotechnology to enhance physical and 
mental abilities that each portray is not. Scientific research has already begun within the 
halls of DARPA, uncovering new ways to leverage advancements in biotechnology in an 
attempt to create soldiers who are more biologically fit to deal with the rigors of complex 
warfare. A common question in the ethical debate is whether there is a need to alter a 
soldiers DNA to increase their performance in combat, how will these scientific 
enhancements increase force effectiveness, and what are the long-term effects of these 
modifications. Science is not there yet, but as research continues these forward thinking 
questions will be easier to answer. For now, the public requires knowledge and awareness 
to help guide legislature and policy. This chapter will discuss what it means to enhance a 
soldier, why this is of importance to the military, how the military has attempted to 
biologically alter soldier using the scientific means of their time, and where 
biotechnology promises to advance the force in preparation for future conflict.  
B. WHAT DOES ENHANCEMENT MEAN?  
Before embarking into further discussion of performance enhancement via 
biotechnological methods there must first be a clear definition of what it means to 
“enhance” the human form. To be precise, the word enhancement is the act of increasing 
or improving something’s magnitude, quality, or value. Thus, the phrase “human 
enhancement” means the process of increasing well-being by improving the human mind, 
physical function, and natural abilities. Therefore, exercising, studying, and maintaining 
healthy diets are, by technicality, acts of enhancement.43 In general, enhancement is an 
uncomplicated term, and the aforementioned techniques are straightforward with little 
public debate of whether they are suitable to enhance human survivability or well-being. 
For this reason, those examples hold little value in further discussion of human 
enhancement throughout this thesis. Nevertheless, the term enhancement, when used in 
                                                 
43 Fritz Allhoff, Patrick Lin, James Moor, and John Weckert, “Ethics of Human Enhancement: 25 
Questions and Answers,” Studies in Ethics, Law, and Technology 4, no. 1, art. 4 (2010): 3. 
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context of applying biotechnology to alter innate human function to achieve the same 
objectives becomes controversial and increasingly difficult to define. Discussion of 
current and future technologies to increase physical performance, though compelling, 
sparks a great deal of ethical debate over how far one should go to obtain perfection 
beyond the typical human dimension.44 There is major public concern of just how far 
scientific research will go to make the actual application of enhancement technologies a 
reality.  Literature centers on the term “enhancement,” yet its definition is ambiguous and 
subjectively defined by the theoretical paradigm of the author.45 Additionally, each of the 
theoretical approaches draw different hypothetical conclusions on the potential 
implication to society that human enhancement poses. Ethicist Robert Veatch states that 
the theory of bioethics is a: 
…comprehensive, systematic account of a general approach to addressing 
an ethical question in the medical or biological sphere. It may be from 
religious tradition or a secular worldview; it may be articulated by health 
professionals or by medical lay people. It may be limited to the medical 
sphere or, more plausibly embedded in a more general ethical theory.46  
This layer of complexity makes reaching agreements on should we, how to, and when to 
genetically optimize the human form a difficult task. Therefore, resolution and future 
application of enhancement technologies to the U.S. military relies heavily upon clearly 
defining the term “enhancement” and establishing a mutual understanding of the end goal 
that it hopes to achieve.  
There are several methods used to define the term enhancement.47 The leading 
and most influential approach is to explain enhancement as a non-medical treatment as 
defined by traditional medical practice. The enhancement vs. therapy approach is 
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commonly employed during talks of performance enhancement via biotechnology 
because of the sector’s linkage to the modern medical process of finding the root cause of 
disease, methods for diagnosing illness and the development of drugs that can target 
specific molecular problems.48 To clarify the distinction between enhancement and 
therapy, bioethicist Eric T. Juengst states that enhancement is the “characterization of the 
intervention designed to improve human form beyond what is necessary to restore, and 
sustain good health.”49 By common definition, “therapy” means to treat disability, 
disease, or impairment by means of medical intervention in order to return a person to a 
normal state of health.50 Conversely, enhancement transcends therapy because it goes 
beyond common medical treatment. Enhancement via biotechnology does not denote the 
use of biology or medicine to fight a disease or repair degeneration. Rather, these 
methods are employed through direct intervention with a healthy human body to improve 
its normal state of physiological or cognitive functioning.51   
Under this guideline, some examples of enhancement are an athlete resorting to 
blood doping to achieve maximum aerobic capacity to increase physical endurance, a 
student without cognitive impairment using Adderall to heighten their ability to learn, a 
pilot that uses stimulants like Dexedrine or Modafanil for extended operations where 
sleep is limited. This meaning carries over into future yet speculative concepts of human 
enhancement where soldiers receive engineered viruses to alter metabolic function 
allowing them to survive weather extremes, run faster, sleep less, and traverse rugged 
terrains like a form of life indigenous to a specific region. Then there are the intelligence-
enhancing genes introduced into a soldiers brain cells via somatic gene transfer to alter 
neural plasticity – the brains ability to undergo physical, chemical, and structural changes 
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in response to stimuli from the external environment and learning experiences.52 This 
will increase intelligence, rapid problem solving and may potentially increase a soldier’s 
ability to process information at the speed of a home computer. 
On the surface, the distinction between enhancement and therapy is useful when 
discerning between which biotechnological interventions are for treatment and that cross 
into the realm of enhancement. The implantation of a pace maker to normalize irregular 
cardiac function is a treatment while the use of anabolic steroids to increase an athlete’s 
performance is enhancement. A deeper analysis reveals that this approach is not without 
complexity because the definitions of medicine and therapy are not always agreed 
upon.53 Most scientists and medical professionals will agree that medicine is an 
evolutionary concept and is not an exact science. What one considers “normal” or “ideal” 
are very subjective terms with different connotations from culture to culture. Thus, when 
using this method, researchers must remain aware of the ever-present grey area in 
terminology that often places a fine line between intervention for treatment and 
intervention for enhancement. These nuances make it difficult to adopt collective 
definitions of medicine and therapy, or establish exact parameters for its application. A 
prominent figure in the bioethics community, Erik Parens states: 
…there is no one universally accepted conception of the goals of 
medicine. The lack of such a consensus has much to do with the fact that 
there is no one universally accepted conception of what health is. And thus 
neither is there a universally accepted definition of what “going beyond 
health to enhancement means.54  
Consequently, the distinction between the two terms is highly sensitive to context and 
ultimately becomes a game of semantics.  
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For instance, if the average male who runs 100 meters between 13–14 seconds is 
given a performance enhancing drug that allows him to run as fast as Usain Bolt, and 
Bolt whose runs a time of 9:58 seconds exceeds the normal range, this intervention is 
considered enhancement. However, if Usain Bolt suffers an injury that impairs his ability 
to run receives the same drug to restore his natural abilities, even though his abilities are 
outside of the normal range for human speed this intervention becomes therapy. A 
different example uses the 20/20 vision standard as the normal range for visual acuity 
even though only 35 percent of the population has 20/20 vision without glasses, 
corrective lenses, or surgery.55 So if the remaining 65 percent of the population 
underwent corrective surgery to achieve 20/20 vision, would this count as therapy, or is it 
enhancement? Some literature also points out the difficulties in determining whether 
immunizations are a form of therapy for prevention or falls into the spectrum of 
enhancement.56 Some scholars believe that immunizations can be a form of enhancement 
because they bolster the immune system prior to exposure. In this case, the body is not ill 
and there is no restoration of health to an original level. However, according to Juensgt’s 
definition, immunizations would work to sustain health and can be a form of prevention. 
Now there is question of whether the definition of intervention is not only sensitive to 
syntax but also to time.57  
Despite its perplexing nature, the distinction between enhancement and therapy is 
suitable to identify potential problems that may arise when discussing the use of 
biotechnology to enhance the physical and cognitive performance of U.S. soldiers. In a 
debate as controversial as human enhancement, having clear definitions of its central 
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terms and a universal understanding of their meanings is imperative. Unfortunately, this 
is not the case and disparities only complicate the task of determining under what 
conditions it is morally correct to proceed with research or apply these enhancements to 
the human soldier.58 Reaching an ethical agreement on the rights and wrongs of human 
enhancement seems as futuristic as the scientific concepts in review. Therefore, it is 
paramount for the DoD to justify the need for biotech enhancement and develop strict 
guidelines for its use if it ever hopes to see its visions realized.  
C. CHANGING CONDITIONS DETERMINE THE NEED FOR ENHANCED 
CAPABILITIES 
One of the principles of evolutionary psychology states that adaptation is the act 
of making up for past shortfalls. Therefore, it is only natural for military leaders to pursue 
new capabilities that will ensure their troops are more fit and prepared to respond to 
changes in national security strategy, and to operate in complex combat environments. 
Rapid advancements in technology have changed the conduct of war. Like the 
introduction of the spear and shield in ancient societies, the invention of the tank, aircraft 
and combat ships have shaped the warfare tactics of modern societies.59 Defense officials 
have witnessed the effects of growing innovations in technology and the enemy’s 
application of its use on the battlefield. Improvised explosive devices (IEDs) and 
explosively formed penetrators (EFPs) activated by long range cellular transmitters came 
as a surprise to forces entering Iraq and Afghanistan. As a result, the military has changed 
its strategy, tactics, and technology to stay abreast of the changing operating picture and 
the nuances of asymmetric conflict. Diminishing conservative strategies along with the 
continued development of more sophisticated enemy operations had triggered a phase of 
transformation within the DoD to create a more dynamic force to maintain battlefield 
superiority and information dominance. An example is the employment of autonomous 
weapon systems like the MQ-9 Reaper UAV that can gather intelligence through 
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surveillance technologies, independently select and discriminate targets, and render lethal 
effects with minimal collateral damage. Though technology continues to evolve and 
increase the lethality of today’s battlefield, it is unimaginable to think that these 
technologies will ever replace the human factor of warfare. The diverse nature of current 
combat operations has heightened awareness of the continued importance of the 
individual soldier. The soldier and his team have always been the most critical integrated 
combat system and like the UAV, these assets require optimization to increase 
performance and promote their effectiveness and lethality of the battlefield.  
The military found that the best way to defeat this asymmetric threat it to employ 
small groups of elite soldiers who are physically and mentally fit to withstand the rigors 
of war. The surge during the Bush administration called for over 92,000 troops to conduct 
counterinsurgency operations in Iraq. To achieve the mandated quota, standards for 
recruitment were lowered, resulting in a force that was very clearly substandard with 
regard to IQ and physical prowess.60 Statistics released by the National Priorities Project 
provide a closer look at some very disheartening data on the quality of U.S. military 
recruits. The report shows that in 2007 only 70 percent of the population of military 
recruits had a high school diploma, which is significantly lower than the traditional 
accession goal of 96.8 percent and a decline not seen since WWII and Vietnam. In the 
same year, based on Armed Forces Qualification Test (AFQT) scores only 44.9 percent 
of recruits were categorized as high quality, which was an 11 percent decrease from 
2005. Another grim detail highlighted in the report shows that the military increased their 
minimum percentage recruitment standard for personnel falling within the “Category IV” 
aptitude range to .4 percent. Soldiers that fall within this category are considered below 
average trainability and past DoD policy restricted Category IV enlistment to no more 
than .2 percent. On a good note, despite not yet meeting prescribed objectives, the quality 
of soldiers within the armed forces is steadily progressing.61 An article by journalist Fred 
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Kaplan states that “a dumber army is a weaker army” and in the era of persistent 
asymmetric conflict soldier are required to be stronger and more intelligent to overcome 
the obstacle imposed by this type of warfare.62 This data does not intend to label the 
military as an institution of idiots rather it shows that in times of increased operational 
need the organization may not get the caliber of personnel it requires.  
In a technical report released in 2003 by Strategic Analysis, Inc., officials from 
the DARPA state that the Peak Soldier Performance (PSP) program was: 
…designed with the vision of enhancing warfighters’ physiological 
abilities and providing them the stamina, strength, and endurance needed 
to complete grueling extended military operations. The mission of the 
warfighter is limited by his/her ability to sustain physical and cognitive 
performance over extended periods of time and in extreme environments. 
At present, the warfighter does not possess the physiological and 
psychological capabilities to keep up with the advances in technology.63  
The 2010 Defense Quadrennial Review Report, the Department of Defense (DoD) 
also asserted its need to focus on evolving and enhancing the force in order to protect and 
advance U.S. interests in the near and long term future while remaining capable of 
conducting full spectrum operations unilaterally or in partnership with allied forces.64 In 
order to create a more dynamic force to remain superior over its adversaries, the DoD has 
expanded its interests in the study of biotechnological enhancement to include continued 
DNA research, studies in genetic engineering, and continued research of the human 
metabolic process to develop better performance enhancing supplements for increased 
energy and endurance. While the programs are still in their infancy, ongoing research 
continues to unlock genetic codes, moving researchers closer to their desired goal of 
creating the “super soldier.” The conceptual super soldier is one who is more decisive, 
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protected, and equipped to survive the battlefield. Their bodies will quickly adjust to 
extreme temperatures, while increased tissue regeneration will promote the rapid wound 
healing and recovery. Soldiers will be able to detect adverse situations and quickly 
traverse complex targets via their optimized ability to solve problems. Heightened 
endurance and lessened fatigue will ensure unit success during extended combat 
operations. The idea is simple: whether a threat is conventional or complex, the soldier 
that possesses more superior physiological and mental capabilities than his enemy will 
prevail.65 Therefore, we must explore the possible benefits of genetic engineering 
because it could potentially lessen the innate limitations of the American soldier bringing 
them to parity with other decisive large platform weapon systems.  
D. FORCE ENHANCEMENT: A HISTORICAL AND MODERN DAY 
PERSPECTIVE 
A warfighter’s effectiveness lies within his or her ability to perform five critical 
functions: command and control, lethality, mobility, survivability, and sustainability.66 
These capabilities are interdependent and their importance and impact vary based on the 
specific combat mission or operational environment. In 1989, the DoD became 
increasingly cognizant of the soldier’s growing importance as an integrative combat 
system. They created the Soldier Enhancement Program (SEP) and the Marine 
Enhancement Programs (MEP). These programs acquire and field enhanced tactical 
equipment to increase survivability, force protection, and lethality of the soldier.67 While 
the DoD has made vast improvements in the individual protective equipment, 
communication and intelligence collection capabilities, soldiers are still highly 
susceptible to the innate limitations of their individual genomes. Soldiers remain at risk 
for disease, vulnerable to extreme weather conditions and they pay a physical toll when 
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negotiating through tough terrain with or without the weight of a combat load. Increased 
pressure on the force, post-traumatic stress disorder (PTSD), and chronic musculoskeletal 
issues are amongst the list of common trends associated with protracted war. A critical 
factor to mention is the effect of stress and fatigue on the decision-making abilities of the 
individual soldier. All of the aforementioned factors contribute to reduced troop 
performance, which is detrimental to combat operations. Most importantly, a 25 cent 
bullet is still very effective at draining the life from the military’s ~$1 million dollar 
investment. Therefore, continued research in human performance enhancement via 
biotechnology enables a closer look inside of the human genome and the ability to 
modify the human body in ways that will remove natural limitations. Ultimately, this 
method may have a positive effect on the military’s ability to fight future conflict.  
The means by which the military is able to enhance a soldier’s performance is 
evolving, but the concept itself is as old as the Revolutionary war. While this thesis does 
not discuss or categorize vaccinations as a form of human performance enhancement, it is 
remiss not to mention that one of the first documented cases of soldier enhancement dates 
back to the American Revolution in 1775–82 when General Washington ordered the 
inoculation of his troops to protect them against small pox.68 The moderately contagious 
virus Variola major caused smallpox, which for England had long been an epidemic. 
This increased the likelihood that British soldier were already immune to the disease 
where American soldiers were not. Taking heed to the detrimental effects of the smallpox 
outbreaks witnessed during the siege of Boston and Quebec, and the mobilization of Lord 
Dunmore’s Ethiopia regiment, General Washington knew that any exposure would 
greatly reduce the operational effectiveness of the Continental Army and would lead to 
its decisive defeat by the British Army. Therefore, he implemented measures to enhance 
his force making them more resistant to what he suspected was a British biological 
warfare tactic. Similar to today’s ethical debates, inoculation was a highly controversial 
topic amongst the American colonials because outbreak of the disease was rare 
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throughout the colonies. Though he lost one percent of his overall force to the adverse 
effects of inoculation, Washington’s risky decision saved the lives of his remaining force 
proving that the need for the enhancement measures outweighed the risk of exposure. The 
program’s success led to its continued implementation in preparation for future 
operations.69  
An equally relevant and more contemporary example of soldier enhancement is 
the use of amphetamines to increase alertness and reduce combat fatigue during extended 
operations. Performance degradation and increased risk for catastrophic accidents such as 
fratricide is the eventual effects of the fatigue seen universally in all soldiers conducting 
sustained operations. Once limited by daylight, the preparation and execution of combat 
operations has become a 24-hour affair. Tactical aviators and some ground forces are 
subject to continuous operations that extend beyond a 24-hour period. Additionally, sleep 
loss and the disruption of natural circadian rhythms are experienced when crossing time 
zones. These factors, combined with preparative work for deployment can produce a 
great deal of operational fatigue and reduce soldier performance.70 When operational 
demands limit a unit’s ability to implement routine rest periods or delay operations until 
soldiers adjust to new environments, leaders have resorted to the use of medications to 
sustain and enhance the performance of their operators.  
Dating back to the 1940s, amphetamines became the drug of choice to maintain 
alertness and reduce fatigue during American military operations. This synthetic drug 
shares a similar chemical structure to the neurotransmitters adrenalin and noradrenalin 
and whether inhaled, ingested, or injected stimulates the release of these natural 
transmitters resulting in a profound effect on brain and muscular activity. During this 
period, amphetamines were widely used in Europe and Japan and by June 1940, the 
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German Army consumed a staggering 35 million tablets of the methamphetamine 
Pervitin. Some scholars believe that the use of this drug drove German success during the 
early stages of the Blitzkrieg.71 During this era, the common hypothesis shared by 
psychiatrists and neurologists was that amphetamines adjusted hormone levels within the 
central nervous system and provided ample stimulation to the brain enhancing alertness 
and muscle control. Therefore, the drug became popular for treating depression, 
narcolepsy, and Parkinson’s disease.72 Considered safe and beneficial for a myriad of 
physical and mental disorders, healthcare providers noticed that continued use decreased 
its effectiveness for appetite suppression. Increasing the dose to maintain the same weight 
loss effect resulted in negative shifts in mood to include irritability, paranoia, insomnia, 
psychosis, and euphoria.73 Another disadvantage was its highly addictive property that 
provides a high potential for abuse.74 These adverse side effects led to the development 
of the protocols used today to govern its distribution and use. Despite the disadvantages, 
these stimulants produced remarkable results when combating fatigue and boredom. 
Studies conducted in the 1940s and 50s showed that when amphetamines were given to 
healthy, non-fatigued individuals their mental acuity increased by five percent and there 
was significant improvement in reaction time and hand eye coordination. Studies also 
showed that in subjects suffering from fatigue with depreciated mental function, using 
amphetamines returned them to normal cognitive levels.75 The results of these studies 
increased the attractiveness of amphetamine because it possessed great utility to prevent 
physical and mental degradation, and helped maintain tactician performance during 
combat operations.   
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During WWII, the American military dispensed the drug Benzedrine in a 5mg 
dose as part of a soldier’s standard issue as well as units medical and emergency response 
kits.76 The use of amphetamines to reduce combat fatigue would extend beyond the Great 
Wars. Because of its ability to maintain alertness for up to 30 hours, dextroamphetamine 
(Dexadrine), known as the “go pill” became a popular drug amongst America’s aviation 
community.77 By 1960, the U.S. Air Force Strategic Air Command (SAC) sanctioned the 
use of Dexedrine, later followed by the U.S. Air Force Tactical Air Command in 1962. 
By Operation Desert Storm, increased medical and administrative oversight resulted in a 
vast improvement of drug effectiveness and pilot acuity. Providers introduced the 
sedative Temazepam (Restoril) also called the “no-go pill” to readjust the circadian 
rhythm to reduce operational fatigue.78 A report from Desert Shield/Dessert Storm states 
that 65 percent of pilots within the TAC used dextroamphetamine to sustain flight 
operations while deployed, which most deemed necessary for mission success.79 Recent 
history has also seen use of dextroamphetamine as a force enhancer for extended flight 
operations. A report by Kenagy et al. shows the rigorous demands of flight operations 
and the use of Dexedrine during Operations Iraqi Freedom and Enduring Freedom. B2 
bomber missions to Afghanistan were in upwards of 44 hours in length and considered 
the longest combat missions in aviation history.80 During these conflicts, aviators 
executed combat and mission support flights that extended beyond a 16-hour period. 
Though amphetamines were common among the tactical aviation community during 
periods of conflict, use of the drug was also found amongst helicopter, tanker, and E-2 
pilots during low stimulus support missions to combat boredom. In the aforementioned 
cases, success may not have been possible without some form of anti-fatigue medication. 
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Recent studies have gone steps further to not only prove the beneficial effects of 
amphetamines on cognition and physical performance, they also investigate how certain 
genetic factors will affect the metabolism of the drug and the potential side effects 
associated with each variant.81 The evidence provided by these reports aids further study 
in the development of newer performance enhancing drugs with less potential side 
effects. The DoD is currently investigating alternative drugs like modafinil, which is 
reported to keep a person awake for 64 to 90 hours without the side effects commonly 
associated with dextroamphetamines.82 In 2012 the Air Force Special Operations 
Command (AFSOC) authorized aviator use of modafinil and extended it operational use 
to its ground forces.83 The drug Ampakine (CX717) is also in test phase but there is little 
data on its effects on human brain function. Though findings are limited, preliminary 
research shows that CX717 has potential for fatigue prevention and performance 
maintenance.84  
The 2002 Tarnak Farms friendly fire incident in Afghanistan forced policy 
makers to take a closer look at the USAF sleep policy and the use of amphetamines 
during combat operations.85 During this event, two American pilots, while under the 
influence of Dexedrine, accidentally killed four Canadian soldiers and injured eight 
others. During the trial, the defense attorneys stated that dextroamphetamine consumed 
by the pilots might have impaired their judgment. This claim led to a public investigation 
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of the effects of amphetamine on personal judgment. While some studies propose that 
amphetamines impair judgment, other studies disprove or report no such finding leaving 
the question of whether amphetamines impair judgment unanswered.86  
Today, all three military services use dextroamphetamine to sustain performance 
within its combat aviation community under circumstances of prolonged operations 
where fatigue is likely.87 Incidents like Tarnak Farms lead to public debate of whether it 
is ethically correct to use amphetamines during military operations. However, critics of 
the current policy sometimes fail to consider the unpredictable and harsh nature of war 
that may require the employment of necessary aids for success.88 Additionally, military 
operators must think beyond their immediate actions, consider the possible implications 
of a failed mission and the effects on the livelihood, and mission success of other service 
members in combat. Therefore, the ethical use of stimulants in combat must be assessed 
within this context and opponents of the policy should consider the higher benefit versus 
risk ratio in this scenario.  
On a smaller scale, but worth mentioning is the military’s interest in nutritional 
supplements to enhance the physical and mental performance of its military personnel.89 
In 2008, the Institute of Medicine (IOM), as a subcommittee under the Committee on 
Military Nutrition Research, began a long-range study to analyze the dietary supplements 
most commonly used among service members and assessed their potential benefits and 
risks to health and physical and cognitive performance. The board’s report states that the 
heightened emphasis on fitness and operational readiness has increased military interest 
to seek dietary supplements to enhance performance beyond what is achievable through a 
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balanced nutritional diet. Therefore, any products that increase physical or mental 
capacity are of special military interest.90 Of the list of supplements examined, those that 
presented the greatest potential for performance enhancement are caffeine (alertness), 
tyrosine (anti-stress), melatonin (sedation), the amino acid hydroxy-methylbutyrate 
(HMB) (lean muscle production for increased strength), creatine (increased physical 
performance with a reduction of injury), and chromium (increased metabolism, strength, 
and weight management).91 The study’s findings show that military use of dietary 
supplements is twice that of the general U.S. populace with 60 percent of U.S. military 
personnel reportedly using dietary supplements as a part of their daily nutritional 
routines. Of this military populace, 85 percent were in the Special Operations 
community.92 The use of dietary supplements may be morally uninteresting because its 
better aligns with societal practices for living a holistic healthy lifestyle. However, the 
findings of this study indicates that subpopulations within the military, like the Special 
Operations or infantry community that undergoes increased levels of physical and mental 
exertion during training and combat express a greater need for performance optimizing 
supplements.  
The examples discussed in this section show the adaptive nature of the military 
and the need to optimize force performance to adjust to changing battlefield conditions. 
Smallpox inoculation and the use of amphetamines were the chosen methods of 
enhancement determined by operational need and scientific advancement of each era. 
Knowledge of the risk and benefits of each of the methods was marginal at best. 
However, leader decisions to apply these enhancement measures allowed for further 
analysis of it potential benefits, which in each scenario became critical factors to overall 
mission success. Therefore, in an era where technological advancement increases the 
lethality of combat and surpasses the natural evolution of man, biotechnology may be the 
method of choice to increase force performance and adaptability in future conflicts. The 
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perceived risks and benefits associated with genetic enhancement are hypothetical and 
the uncertainty causes great concern, but concern should not prevent further 
investigation, because without it the actual benefits will go unknown.  
E. BIOTECHNOLOGY: THE BREAKTHROUGHS AND DOWNSIDE OF 
GENETIC ENGINEERING 
Human enhancement requires the convergence of four field of science—
nanotechnology, biotechnology, information technology, and cognitive science (NBIC).93 
While each play a significant role in enhancing performance, biotechnology opens the 
gateway to the human genome and allows an in-depth look at the basic building blocks of 
life—DNA. Understanding how the body functions at the molecular level presents 
opportunities to biologically modify human physiology and cognition to maximize 
overall effectiveness.94 Where scientists were once limited to temporary solutions to 
maintain and maximize performance, biotechnology may provide a permanent fix to the 
natural limitations one seeks to eliminate (i.e., pain, fatigue, and stress).  
The biological revolution of the 1970s began an era of scientific innovation that 
led to the discovery of new methods and products that would reshape medical practices 
and discoveries to enhance human performance. While most of the breakthroughs and 
application of biotechnology occurred within the last 30 years, the scientific practice 
began over a hundred years ago with the discovery of DNA.95 Biotechnology applies the 
practice of engineering to the life sciences in order to enhance the human condition, and 
protect the force in time of conflict. Some would also argue that biotechnological 
advancements will make the conduct of war more humane and will reduce American 
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post-reconstruction efforts and long-term political ramifications.96 Biotechnology has 
exhibited endless potential within the realm of medicine. To date, the growing industry is 
primarily responsible for over 50 percent of medical innovation.97  
A beneficiary of the Human Genome Project (HGP), biotechnology embarks on 
new methods to redesign organisms at the genetic and molecular levels. The HGP 
provides a basic understanding of the genetic structure of an organism in relations to its 
function and health. The genomic roadmap provided by its research has moved science 
from an era of DNA sequencing to an era of DNA synthesis. Findings of the HGP 
revolutionized the biotechnology industry and triggered innovations within a broad range 
of biotechnologies to include genetic engineering, bioinformatics, proteomics, and 
transgenic technology. Genetic engineering is the direct modification of an organism’s 
genes through techniques that remove innate material or replace it with exogenous DNA 
that is directly inserted into a host or a cell. The end goal is to fuse or hybridize new 
DNA with a host to alter its form and or function. Bioinformatics studies the gene and 
protein molecules, which are the crux of organism development. Continued research 
within this realm provides scientist with an in depth review on how to manipulate DNA, 
the conductor of genetic development and functioning. Proteomics takes scientific 
investigation a step further by examining the function of key proteins that control human 
physiology, and the multitude of physiological functions a single protein can possess. 
Current findings in proteomic research has identified proteins role in neurotransmission, 
cell reproduction, tissue growth, blood production, and immune response to disease.98 
Last, studies in transgenic technology provide some concept of gene control and 
reconstitution. While research in this realm of study is limited, transgenic studies 
continue to open new gateways to advanced genetic manipulation.99 Ultimately, 
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successful biotechnologies will change a living organism’s ability to perform new 
functions. For the military, this means a deeper understanding of how to control or 
change a soldier’s battlefield effectiveness.   
In 2010, a study conducted by the JASON Group, a scientific advisory group to 
the U.S. government, identified the U.S. military as the top consumer of medical services 
because they possess unique medical needs that surpass those of the general population. 
For this reason, the military will greatly benefit from innovations in genomic research 
because it will enhance the medical capabilities of the military and facilitate greater 
treatment outcomes.100 JASON’s research shows that continued genomic research may 
greatly impact offensive and defensive operations because the application of genomic 
technologies may enhance soldier fitness, performance, and operational readiness.101 
Through its medical data systems, the DoD is more than equipped to receive and store, 
analyze and secure the genotypic and phenotypic information of its service members. 
This data will allow researchers to better understand individual responses to battle-
fatigue, susceptibility to PTSD, prolongued exposure to extreme weather conditions, and 
rate of recovery of injury.102 Their research, access to a large population of personnel, 
medical data storage, and their ability to leverage support from civilian biotech agencies 
will allow the DoD to greatly contribute to realm of biotechnology and realize its 
concepts for force enhancement.  
DARPA is underway in their attempts to develop tools to enable genetic 
engineering that may one day enable the DoD’s ability to create a biological fit soldier. 
Through their “Living Foundries,” program DARPA’s hopes to “enhance methods for 
genome transplantation that will enable the engineering of complex functionality into 
human cell lines than are currently possible.”103 Within the program, there are several 
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areas of interest, to include developing tools for rapid gene construction and editing and 
manipulating genetic designs. By soliciting the help of private biotech corporations, 
DARPA aims to improve their methods to implant human artificial chromosomes 
(HACs) into mammalian cells as highlighted in a document on the DoD’s Small Business 
Innovation and Research page. The idea of genetic enhancement seems like it is rooted in 
science fiction, but the following examples of ongoing research gathered from open 
source information will provide sufficient evidence of its reality. 
1. Anti-Fatigue 
Sleep and the reduction of mental fatigue are the most heavily researched areas in 
human performance. Currently, stimulants like caffeine and modafinil provide a 
temporary solution to counter fatigue. However, findings from recent fatigue studies 
indicate a genetic component associated with fatigue and has found that some humans are 
naturally resistant to mental exhaustion.104 Scientists are uncovering genes that control 
specific aspects of sleep, creating a genetic map that can one day become the key to sleep 
regulation and reducing fatigue in humans.105 
2. Enhancing Mental and Cognitive Function  
In a study conducted by Tang et al., researchers successfully enhanced the 
learning and memory in laboratory mice by genetically modifying the synaptic response 
of neurons ultimately altering brain plasticity and memory formation. The findings of this 
study lead researchers to believe that genetic enhance of mental and cognitive abilities in 
mammals is possible.106  
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3. Physical Enhancement 
In an attempt to study muscle disease and reverse a loss in muscle mass associated 
with aging, McPherron et al. genetically engineered laboratory mice to have increased 
muscle growth and strength. Scientists discovered that the blocking of specific growth 
factor genes through gene targeting increased skeletal muscle mass in laboratory 
specimens.107 Researchers continue to study the Myostatin gene and its effect on elite 
athletic performance.108 
4. Immunity 
The 2008, scientist joined forces to launch the Immunological Genome Project to 
develop a “road map” of the genes that control various immune cells. Increased 
knowledge of the immune system may allow scientists to genetically modify cellular 
function to help treat or prevent exposure to infectious disease.109 
5. Pain Management 
Pain reduction is of major interest to researchers. Increasing pain thresholds and 
decreasing the inflammatory response associated with injury may reduce mental and 
physical stress that can degrade performance.110 One of the leading biotech companies, 
the Rinat Neuroscience Corporation created the RN624 pain inhibitor vaccine that blocks 
pain within 10 seconds with results that last for 30 days. While the serum does not 
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remove the initial sensory response of an injury, it significantly reduces the inflammation 
and swelling that are responsible for pain.111  
6. Anti-aging 
Research conducted by a team of UCLA scientist uncovered a “biological clock” 
embedded within the genome that promotes the aging of tissue. By chemically altering 
human DNA, scientists were able to create an internal clock that accurately determined 
the age of various organs, cells, and tissues while identifying parts of the body that aged 
faster than others did. Geneticist Steve Horvath states: 
“the process of transforming a person’s cells into pluripotent stem cells 
resets the cells’ clock to zero. The big question is whether the biological 
clock controls a process that leads to aging. If so, the clock will become an 
important biomarker for studying new therapeutic approaches to keeping 
us young.”112  
7. Human Regenerative Healing  
Scientific studies are uncovering ways to manipulate the genes to make humans 
regenerate like a newt, flatworms, and the hydra. The study led by Ellen Heber-Katz, a 
professor at the Wistar Institue in Philadelphia, found that by deleting the p21 gene in 
laboratory mice reactivated the ability for cells to renew surgically removed tissues 
without signs of scarring or previous damage. The study was successful in finding the 
genetic link to tissue regeneration yet further research is necessary to control implications 
caused by the removal of the gene. A thorough understanding the implication of their 
finding will allow researchers to one day be able to accelerate healing in humans.113 
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F. FEAR OF THE UNKNOWN 
While this field of science shows great benefit towards the future protection and 
enhancement of the human condition, genetic engineering also possesses a downside. Its 
unpredictable nature generates questions of its safety and the potential side effects of 
modifying genetic pathways. Additionally, some of the methods used to introduce new 
genes into the human body can threaten health and potentially lead to death. The human 
genome is a complex system of cells that are responsible for a multitude of functions, 
biological signals, and pathways. Alteration requires a level of mastery that scientists 
have not yet obtained. For instance, disrupting one gene to treat a defect may cause other 
problems. Scientists found that blocking the gene to increase intelligence in mice also 
leads to an increase in sensitivity to pain.114 A study performed by Heber-Katz et al. 
(2009) revealed similar findings. Their research found that prohibiting the functionality 
of the p21 gene promoted increased tissue regeneration but also removes the body’s 
natural ability to regulate production of the p53 gene can lead to its uncontrollable 
proliferation, which, if not controlled, can lead to the overproduction of cells that can 
lead to some cancers or aptosis - increased cellular death.115  
Gene therapy using recombinant DNA (rDNA) is the oldest and most common 
technique for moving exogenous genes into a host. This method uses live biological 
vectors like plasmids or viruses to deliver rDNA into an individual’s genome to repair 
genetic mutations. The vector must surpass the immune system and properly target its 
specified cell. Any error can lead to increased complications. As witnessed in a small 
number of gene therapy cases complications could lead to subject death. In the reported 
circumstances, death was due to severe immune reactions to the vectors and transgenes, 
or the inappropriate insertion of a viral vector and transgene that led to viral propagation 
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or cancer causing mutations.116 Additionally, any mishap when engineering rDNA 
transfer vectors could lead to the creation of a stronger and more resistant virus or 
bacteria. If released, these germs could theoretically cause a major epidemic. 
The aforementioned issues address some of the known negative or potentially 
negative side effects of genetic engineering. However, the most frightening aspect is not 
knowing the answers to the unknown questions associated with this field of science. 
There is no clear understanding of the long-term effects or the implications of altering 
DNA. The unknowns naturally lead to reluctance, controversy and pointed arguments 
over its potential effects and the parameters of research. The science remains unperfected, 
unpredictable, and uncontrollable. Despite this, continued scientific research leads to 
discovery of these issues and allows for the development of effective solutions to make 
genetic engineering a stable practice.  
G. CONCLUSION 
This chapter analyzed the concept of enhancement, the military’s operational need 
for it, and how breakthroughs in genetic engineering could soon create more biologically 
fit soldiers. Despite the wars in Iraq and Afghanistan drawing to a close, it is only a 
matter of time before conflict abroad calls for America’s attention. As history shows, the 
conduct of war evolves over time and with radical advancements in technology, the 
battlefield will become more lethal and complex. Modern advancements in 
biotechnology, though radical, may someday help the military fill capability gaps by 
creating a force more physiologically and intellectually fit to survive the rigors of future 
conflict. Technological capability for such an endeavor is years from existing. 
Nevertheless, further research to assess the risks and benefits associated with genetically 
modifying soldiers should undoubtedly continue. It is up to DoD to decide the pros and 
cons of genetic engineering and establish policy to determine which methods should be 
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used or prohibited. In the meantime, increasing awareness and quelling public concerns 
surrounding genetic modification is essential to prevent the disruption of further research 
and future military application of genetic enhancements. The next chapter will conclude 






IV. CONCLUSION  
In the post 9/11 era, America’s policy makers are challenged by changing world 
politics and how to best implement its military to maintain order throughout the 
international community and secure U.S. national security and interest. Robert Mueller, 
former Director of the Federal Bureau of Investigation, best describes the erratic changes 
in global politics and rising threats by stating, “Surveying today’s threats is somewhat 
like peering into a kaleidoscope, where even the slightest rotation creates new patterns of 
color and light. Just when it seems you understand a threat, the world turns, and the 
threat has changed [emphasis added].”117 Staying ahead of the threat means increasing 
the operational demands on the military. Military leaders are responsible for balancing 
operational requirements while ensuring the greatest level of force health protection, 
which is a challenging task. To meet the demands of persistent and complex warfare, 
military leaders must investigate new technologies that will enable the optimization of 
force performance and effectiveness when operating in current and future battlefield 
conditions. As discussed in previous chapters, the military places great emphasis on the 
development of advanced weapon systems to outmatch its enemy, however, in an era of 
prolonged dual-front warfare, leaders are realizing more the importance of the soldier as 
an integral weapon system and the most critical element of mission success. Though the 
soldier is identified as being an eminent asset in the military’s arsenal of weapon systems, 
the soldier is the weakest link due to its natural genetic limitations. Unlike inanimate 
advanced large platform weapon systems used to produce lethal effects on the battlefield, 
the human soldier is vulnerable to his or her own biological constraints as well as 
environmental and occupational factors that can adversely affect health and 
performance.118 While it may be slightly absurd to think that fighting wars could ever be 
                                                 
117 Robert S. Mueller, “Changing Threats in a Changing World: Staying Ahead of Terrorists, Spies, 
and Hackers,” Federal Bureau of Investigation, November 17, 2011, accessed on June 4, 2013, 
http://www.fbi.gov/news/speeches/changing-threats-in-a-changing-world-staying-ahead-of-terrorists-spies-
and-hackers/.  
118Lester Martinez-Lopez, “Biotechnology Enablers for the Soldier System of Systems,” The Bridge 
34, no. 3 (2004): 17.   
 50 
an easy process, biotechnology may one day enhance soldiers beyond their inherent 
genetic shortfalls making it easier and safer for them to operate on the battlefield and 
withstand the rigors of war.119  
Human enhancement techniques have a long lineage throughout military history 
and continue to evolve over time. Of the DoD’s list of paradigm-shifting technologies, 
biotechnology has become a front runner in scientific and technological innovation that 
may facilitate the successful transformation of the U.S. military into a fast acting, highly 
networked joint force capable of rapid deployment, increased decision making while 
maintaining its ability to achieve battlefield superiority.120 DARPA scientists are moving 
their research beyond the development of advanced external body armor to the 
investigation of methods to enhance strength and endurance, metabolic response, fatigue 
resistance, rapid healing and cognition. They have begun to divert their attention to 
improving the internal workings of the human being to enhance soldier fitness from the 
inside out. Scientist are leveraging emerging biotechnologies that promise great 
technological advancement that may provide the military with unprecedented capabilities 
by shaping the future of human performance and creating a soldier who is more decisive 
and effective in combat. Scientific and technological advancements are occurring at an 
unprecedented pace, shifting the concept of genetic engineering of the human genome 
from science fiction to reality. Concepts once portrayed in movies and comic books may 
become the realized future of the military. Ongoing research in genetic engineering 
continues to unlock genetic codes that may one day enable the successful and stable 
enhancement of a soldier’s physical and cognitive condition. By removing what some 
scientists consider “genetic imperfections,” soldiers may be able to endure the extremes 
of weather and terrain, heal and recover faster, move quicker, survive longer without 
nutritional sustenance, and think in ways that transcend normal human abilities.  
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As highlighted in Chapter II, there is an expected level of social angst when 
discussing or dealing with futuristic ideas where the possible outcomes are unpredictable 
and have the potential of producing uncontrollable effects that may alter human life. 
Research shows that the uncertainties surrounding the new technologies are highly 
speculative and farfetched. At this point, no one really knows the real outcomes of 
biotechnological research and how its byproducts may affect human life in the future or 
specifically, the life of a soldier and his or her conduct in future wars. There is little 
debate over innovations in science and technology that have led to great medical 
breakthroughs such as the creation of new pharmaceuticals, cures for diseases, bodily 
dysfunction, and the replacement of organic limbs and organs. However, when the use of 
science and technology extends beyond the restoration of health and becomes a tool to 
alter the human form from its normal state some scholars believe that it challenges the 
essence of what it means to be human and threatens societal values. At the core of this 
argument is the belief that genetically modifying the human genome makes humans look 
like artificial life forms that can be manipulated either for their own personal desire or for 
the needs of society. Most of the presented literature discusses the effects of 
biotechnology on the general American populace and how far people may go to increase 
their well-being and lifestyles via genetic modification. There is little analysis of its 
application to the military to enhance a population of soldiers that sacrifice their lives for 
the security of the nation and how these same technologies will reduce risk and increase 
personal sustainment during complex operations. Therefore, the ethical use of 
biotechnology to genetically enhance an individual based on duty, responsibility and 
level of risk associated with their occupation demands further analysis.  
Regardless of which side of the ethical debate one may be on, none can deny the 
importance of human performance and the need for the military to maintain its 
performance advantage to achieve victory in war. Examples discussed in chapter three 
are the military’s use of neuro-pharmaceuticals (dextroamphetamine, modafanil, and 
ampakine “CX717”) to support extended flight operations and the use of performance 
enhancing supplements by over 85 percent of the military’s most elite forces. These 
medications and holistic supplements greatly enhanced athletic performance, cognition, 
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concentration, and alertness during high stress combat operations where mission success 
depended greatly upon the ability to combat sleep deprivation and battle-fatigue.  The 
high percentages of use of the anti-fatigue medications and dietary supplements further 
support the notion that performance is a critical part of military culture. Nevertheless, 
ethical considerations will limit research activities and the application of genetic 
enhancements to the force. Furthermore, unclear definitions of human enhancements, 
poorly established limits in medicine, and theological beliefs on the limits of science will 
continue to complicate reaching an agreement of whether the military should or should 
not genetically enhance soldiers.  
A. POLICY IMPLICATIONS 
While the debate continues, advances in science and technology are outpacing the 
development of policy that may inhibit or facilitate the life sciences that may one day 
allow the military to create its “super soldier.” Due to complex and novel set of ethical, 
legal, and social issues associated with the use of genetic enhancements, it is of the 
utmost importance that the DoD increases public awareness of their need for human 
enhancement technologies. Gaining public support for the military to apply this type of 
enhancement method to its force is dependent upon the DoD’s ability to clearly establish 
guidelines for and limits of its use. Critical questions that remain unanswered is will 
genetic enhancement technologies be applied to the entire force or targeted sectors 
depending upon the complexity of its military mission and whether these enhancements 
are reversible once a soldier has completed their tour of duty or military obligation? 
Obtaining the answers to these questions may not be possible for some time because the 
future of warfare is a hypothetical concept and research in genetic modification is still in 
its infancy with findings that are inconclusive. Therefore, future success in ensuring the 
development of policy that will facilitate the application of biotech enhancements lay in 
the scientific community’s ability to communicate the importance of genetic 
enhancement research and its role in ensuring force health protection. 
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